Abstract. A simple but novel mixed surfactant system was designed to fabricate a self-nanoemulsifying drug delivery system (SNEDDS) based on hydrophilic-lipophilic balance (HLB) value. The impacts of HLB and molecular structure of surfactants on the formation of SNEDDS were investigated. as inert solid carrier. Solid SNEDDS formulations using higher amounts (30-50% w/w) of Aerosil ® 200 exhibited good flow properties with smooth surface and preserved the self-emulsifying properties of liquid SNEDDS. Differential scanning calorimetry and X-ray diffraction studies of solid SNEDDS revealed the transformation of the crystalline structure of NDP due to its molecular dispersion state. In vitro dissolution study demonstrated higher dissolution of NDP from solid SNEDDS compared with NDP powder.
INTRODUCTION
A major problem in oral drug formulations is the low bioavailability of active drugs. This may lead to high intersubject and intra-subject variabilities and therapeutic failure. The improvement of drug bioavailability presents one of the most challenges in drug formulations. One of the most interesting approaches is the use of a self-nanoemulsifying drug delivery system (SNEDDS) (1, 2) . SNEDDS is anhydrous form of nanoemulsions or preconcentrated nanoemulsions. It is an isotropic mixture of oil, surfactant(s), and drug, which spontaneously forms thermodynamically stable oil-in-water nanoemulsions (usually with globule size <200 nm) when introduced into the aqueous phase under gentle agitation conditions (3) . SNEDDS can also contain a co-emulsifier or cosurfactant and/or solubilizer to facilitate nanoemulsification or improve drug incorporation. The advantages of SNEDDS include the possibility of filling them into unit dosage forms (e.g., soft/hard gelatin capsule), maintaining physical and/or chemical stability upon long-term storage, improving the bioavailability of poorly water-soluble drug, and reducing the blood profile variation in the patients confronted with gastrointestinal (GI) problem (4, 5) . However, the SNEDDS as liquid dosage forms has limitations such as low drug loading capacity and excipient-capsule incompatibility (2, 6) . To overcome these complications, the liquid SNEDDS is adsorbed onto inert carrier, such as silicon dioxide, to produce solid SNEDDS.
In the formulation of a SNEDDS, the following points should be considered: (1) solubility of the drug in different oils, surfactants, and cosurfactant/cosolvents and (2) selection of oil, surfactant, and cosurfactant/cosolvent based on the solubility of the drug. The optimum concentrations of oil, surfactant, and cosurfactant/cosolvent necessary to promote selfemulsification are determined by the construction of a ternary phase diagram. However, the experimental determination of a phase diagram is a time-consuming process, requiring careful synthesis and characterization of all phases in a system. Wang et al. (7) proposed an alternative method to prepare SNEDDS containing a mixture of surfactants with similar structure (i.e., ethoxylated sorbitan monoester-type hydrophilic surfactant (Tween ® ) and sorbitan monoester-type lipophilic surfactant (Span ® )) by calculating hydrophilic-lipophilic balance (HLB). Although the HLB system is not absolute in predicting the formulation behavior, it is a very good starting point for achieving emulsification (8) .
The HLB of the surfactant offers essential information on its potential use in the formulation of SNEDDS. The SNEDDS formulation with high HLB surfactant can form oilin-water nanoemulsions that immediately and rapidly spread in the aqueous medium. It would keep the drug solubilized for a prolonged period of time at the absorption site for effective absorption and prevent drug precipitation within the GI lumen (9) . More than one surfactant may be blended together to achieve the desired HLB. A mixture of different surfactant types often exhibit synergism in their effects in the properties of a system. This synergism can be attributed to nonideal mixing effects in the aggregates, resulting in critical micellization concentration and interfacial tension that are substantially lower than that expected on the basis of the properties of the unmixed surfactants (10) . In addition to the appropriate HLB value, the constitution and molecular structure of mixed surfactants on the water/oil interface is also an important factor affecting the formation of nanoemulsions after dispersion in a medium. Recently, Wang et al. (7) reported that different pairs of surfactants with similar structure (i.e., Tw e e n ® a n d Sp a n ® ) a t t h e o p t i m u m H L B v a l u e corresponding oil phases provide different droplet sizes depending on the molecular structure of the surfactant. To date, there are a limited number of published reports available in the literature that have prepared the SNEDDS by using mixed surfactants of polysorbates based on the HLB of the mixture (e.g., 7,11). The pharmaceutical nanoemulsions are often composed of other surfactants with different structures, for example, polyoxyls, which has not been reported in the literature. Therefore, it is interesting to investigate the effect of the HLB of different blends of surfactants.
For a poorly water-soluble drug, drug dissolution was the slowest step during the drug absorption process, causing low drug bioavailability. In this study, nifedipine (NDP), a wellknown and most widely used coronary vasodilator from the group of dihydropyridine derivatives, was chosen as a model drug. NDP is practically insoluble in water, with a solubility of 5.8 mg/L in water, pK a <1, and log P of 2.50 (12) . Numerous attempts have been made to improve its therapeutic efficacy and patient compliance, for example, pellets, granules, microparticles, and solid dispersions using different carriers (e.g., urea, lactose, polyethylene glycol, polyvinylpyrrolidone, phospholipids, polycaprolactone, acrylic polymers, etc.).
In the present study, the solid SNEDDS containing NDP was developed based on the HLB of mixed surfactants. To select the oil and surfactant in the formulation, the solubility of NDP in various vehicles including oils and surfactant was determined. Different surfactants and their combinations, depending on the HLB value, were used for preparing SNEDDS. Solid SNEDDS was prepared by mixing the SNEDDS with inert solid carriers. The SNEDDS and solid SNEDDS were then characterized for their size after dispersion, morphology, physicochemical properties, and drug dissolution behavior.
MATERIALS AND METHODS

Materials
NDP was purchased from Xilin Pharmaceutical Raw Material Co., Ltd. (Jintan, China). As NDP was light-sensitive, all samples were kept in an amber-colored container or wrapped in aluminum foil during the whole experimental process. Olive oil, castor oil, sunflower oil, almond oil, apricot oil, and coconut oil were purchased from P.C. Drug Center (Bangkok, Thailand 
Determination of Drug Solubility in Various Vehicles
The solubility of NDP was determined in various vehicles by adding an excess amount of NDP (500 mg) in 1 mL of pure vehicle in glass tubes. The drug suspension was equilibrated at 25°C in a thermostatically controlled bath for 72 h. After equilibration, the tubes were centrifuged at 3,500 rpm for 15 min and the clear supernatants were analyzed for NDP with a high-performance liquid chromatography (HPLC; model JASCO PU-2089plus quaternary gradient inert pump and JASCO UV-2070plus multiwavelength UV-Vis detector; Jasco, Tokyo, Japan) using Luna 5u C18 column (5 μm, 4.6 nm× 25 cm) (Phenomenex, Torrance, CA, USA). The mobile phase composing of water, acetonitrile, and methanol (50:25:25) was filtered through a 0.22-μm membrane filter and degassed in a sonicator bath before use. The flow rate of the mobile phase was 1 mL/min, and the UV detection wavelength was 235 nm.
Preparation of Mixed Surfactant System
A frequently used method for the selection of surfactants is known as the HLB method. 
where HLB A and HLB B are HLB values and f A and f B are the weight fractions of surfactant A and surfactant B, respectively. The HLB mix required in this study ranged from 8 to 15 (13) .
The surfactant mixing ratio calculated from the previously mentioned equation was defined as the weight percent of the corresponding surfactants, as shown in Table I .
Preparation of SNEDDS Formulations
Preparation of Liquid SNEDDS
The formulations were prepared by mixing oil (Imwitor ® 742) with mixed surfactant systems at a ratio of 1:1. The formulations were stored at ambient temperature (25°C) until further use. Selected formulations that corresponded to an HLB mix of 10 were loaded with NDP at the concentration of 30 mg/mL. Drug-loaded formulations were stored in the amber glass container, at 25°C, for 3 days to observe immediate stability. Unstable formulations (e.g., precipitation of drug crystals and/or phase separation) were excluded from the study.
Preparation of Solid SNEDDS
Selected SNEDDS formulations were simply adsorbed onto two types of silicon dioxide, i.e., Aerosil ® 200 (hydrophilic grade) and Aerosil ® R972 (hydrophobic grade), by trituration using 20%, 30%, 40%, and 50% (w/w) silicon dioxide in the formulation.
Characterization of SNEDDS
The formulations were reconstituted by gentle mixing in distilled water at a dilution ratio of 1:100. The mixtures were gently folded and stored at ambient temperature (25°C) for 2 h before further characterization. In case of solid SNEDDS, the mixtures were also centrifuged at a speed of 2,000 rpm for 10 min to separate the solid carriers.
Visual Observation of Self-emulsification
Evaluation of the self-emulsifying properties of SNEDDS was visually observed (i.e., until a clear homogenous system was obtained).
Droplet Size Analysis
The droplet size of the emulsion formed after reconstitution of SNEDDS was determined by static laser light scattering (model LA-950; Horiba, Kyoto, Japan). Reconstituted samples were withdrawn and diluted to a final droplet concentration of approximately 0.05% (w/w) with distilled water. The instrument measured the angular dependence of the intensity of the laser beam scattered by the dilute emulsions and then used the Mie theory to calculate the droplet size distributions that gave the best fit between theoretical predictions and empirical measurements. A relative refractive index of 1.2 (ratio of the indices between the oil and water phases) was used. All measurements were repeated three times, and the values of mean diameter were reported.
Morphology Examination of Solid SNEDDS
The external structure of the solid SNEDDS was investigated by a scanning electron microscope (SEM; model Maxim-2000; CamScan Analytical, London, England) with an accelerating voltage of 15 keV. The samples were fixed on a stub using double-sided adhesive tape and coated in a vacuum with thin gold layer before investigation.
Solid State Characterization of Solid SNEDDS
The physical state of NDP in solid SEDDS was characterized by differential scanning calorimetry (DSC; model Sapphire DSC; Perkin Elmer, Waltham, MA, USA). The samples were placed in standard aluminum pans and scanned at a temperature ramp speed of 10°C/min and heat flow from 20°C to 200°C. Furthermore, powder X-ray scattering measurements were carried out with a powder X-ray diffractometer (PXRD; model MiniFlex II; Rigaku, Tokyo, Japan) at room temperature using monochromatic CuK α radiation at 15 mA and at 30 kV over a range of 2θ angles from 5°to 40°w
ith an angular increment of 4°/min.
In Vitro Dissolution Study
The dissolution test was carried out using a USP dissolution apparatus II (Pharma Test, Hainburg, Germany) with 900 mL of simulated gastric fluid (SGF) USP without pepsin (pH 1.2) as a dissolution medium at 37±0.5°C. The paddle speed was adjusted to 50 rpm. Different formulations (NDP powder, liquid SNEDDS, and solid SEDDS (A40 and A50)) filled in hard capsules (equivalent to 10 mg of NDP) were put into a sinker before placing in a dissolution vessel, which was protected from light. At predetermined time intervals (i.e., 5, 10, 15, 30, 60, 90, and 120 min), 5-mL aliquots of the medium were collected, filtered through 0.45-μm nylon membrane filters to remove the agglomerated silicon dioxide, and analyzed for the NDP concentration by HPLC analysis as mentioned previously. The same volume (5 mL) of fresh medium was added to compensate for the loss due to sampling. The dissolution experiments were carried out in triplicate.
Statistical Analysis
Analysis of variance and Levene's test for homogeneity of variance were carried out using SPSS version 10.0 for Windows (SPSS Inc., Chicago, IL, USA). Post hoc testing (p<0.05) of the multiple comparisons was performed by either the Scheffé or Games-Howell test depending on whether Levene's test was insignificant or significant, respectively.
RESULTS AND DISCUSSION
Solubility of NDP in Various Vehicles
In the formulation of SNEDDS, the selection of suitable oil, surfactant, and cosurfactant has an important role in enhancing the solubility of drug and drug loading. The components in SNEDDS formulations should be selected to have maximum drug solubility along with good miscibility with each other to produce a stable formulation (14) . The solubility of NDP in various vehicles is presented in Table II . Higher solubility of NDP in the oil phase was an important criterion, as it would help the nanoemulsion to maintain the drug in solubilized form. Among the oils and fatty acids tested in this study, Imwitor ® 742 (caprylic/capric glyceride), which is an amphiphilic compound with surface active property, showed 3) demonstrated the minimum solubilizing capacity for NDP. It could be seen that the solubility of NDP was dependent on the HLB of the surfactant; that is, the higher the HLB, the higher the solubility of NDP. The solubility of NDP in some organic solvents has also been tested as shown in Table II . This information can be used for selecting a suitable system for HPLC analysis.
Preparation and Characterization of SNEDDS
A surfactant dissolved in liquid can either adsorb at the interface or self-assemble to form micelles, resulting from the hydrophobic effect. The lyophobic group of the surfactant tends to be expulsed from the liquid in which the surfactant is dissolved. The adsorption of surfactants at the interface induces a structural change in the interfacial area and, in many cases, a decrease of the interfacial tension. It seems obvious that, by changing the surfactant, the interfacial tension decreases to a different degree which affects the final droplet size (16) . The HLB method has been demonstrated to be a useful tool in selecting the optimal type of surfactants for a certain oil phase (11) . SNEDDS was prepared with 50% (w/w) oil phase and 50% (w/w) mixed surfactants at HLB values ranging from 8 to 15. Eight series of mixed surfactants, consisting of four different types of hydrophilic surfactants (i.e., Tween ® 20, Tween ® 80, Cremophor ® RH40, and Cremophor ® EL) and two types of lipophilic surfactants (i.e., Span ® 20 and Span ® 80), were examined to determine the suitable HLB to obtain SNEDDS. Blends of surfactants at various ratios were used to prepare mixed surfactants with a range of HLB values ( Table I) .
The effect of the HLB of different mixed surfactants on the droplet size of emulsions obtained after dispersion in aqueous medium is shown in Figs. 2 and 3 . The results suggested that, even though the HLB values were the same, there is a wide difference in the emulsion droplet size. It is obvious that the droplet size depended primarily on surfactant molecular structure. Nanoemulsions could be formed from mixtures of Cremophor ® and Span ® at suitable HLB (Fig. 2) . It could be seen that the droplet size decreased when the HLB of mixed surfactants (Cremophor ® /Span ® ) was >9 for those using Span ® 80 and 11.5 for those using Span ® 20. At an HLB of 10, for example, mixtures of Cremophor ® (polyethoxylated castor oil, which is a blend of ricinoleic acid, polyglycol ester, glycerol polyglycol esters, and polyglycols) and lipophilic surfactant with longer CH chain length (C18, Span ® 80) produced the nano-sized emulsion, while those with shorter CH chain length (C12, Span ® 20) provided only micron-sized emulsion. From Fig. 2 , it is observed that the increase in HLB exhibited a decreasing trend; that is, the emulsion droplet size decreases with a higher HLB. Based on the HLB calculation, higher values indicate that surfactants have higher hydrophilicity, which facilitates reduction in the curvature of the interface for the oil that own relatively high solubility, leading to smaller droplet size (17) . This is the possible reason for the decreasing trend in emulsion droplet size.
In contrast, nanosized emulsions could not be obtained in the system containing Tween ® and Span ® (Fig. 3) . In any combination of Tween ® and Span ® , the emulsion droplet size was not significantly different (approximately 10 μm). The correlation between HLB and mean droplet size demonstrates the nearly linear line rather than the sigmoid curve reported previously (7) . This is probably attributable to the absence of cosurfactant in our experiments. In their formulations, however, the cosurfactant (i.e., 1,2-octanediol) is added in the formulations containing mixtures of Tween ® 80
and Span ® 20. The addition of 1,2-octanediol decreases the surfactant content necessary to produce nanoemulsions and significantly affects the droplet size (7) . Without the cosurfactant, it is difficult to reduce the effective HLB to a value within the range required for nanoemulsion formation. Figure 4 shows the schematic representation of the configuration into oil-in-water (nano)emulsion. The results are in agreement with Dai et al. (18) who reported that the molecular structure of the surfactant has a significant effect on the final emulsion droplet size. However, the change in hydrophilic surfactant (Cremophor ® EL and Cremophor ® RH40) in mixed surfactants, when the lipophilic surfactant remained unchanged, did not influence the emulsion droplet size. This means that the structure of Cremophor ® has a greater effect on the droplet size than that of Span ® . These results suggested that the difference in CH chain length between Cremophor ® and Span ® assisted the formation of nanoemulsions. However, at HLB=12-13, nanoemulsions can be produced from all Cremophor ® and Span ® blends. It seems that a branch alkyl structure of both Cremophor ® EL and Cremophor ® RH40 had an effect on the penetration of oil onto the curved film interface, thus resulting in the self-formation of nanoemulsion (19) .
Molecular modeling and docking studies of Cremophor ® EL and γ-tocotrienol were reported by Alayoubi et al. (20) . The low-energy docked structures clearly suggested that γ-tocotrienol binds to Cremophor ® EL deep inside the hydrophobic pocket. For Cremophor ® EL, it was observed that most of the low-energy structures are formed when the isoprenyl group of γ-tocotrienol is docked near the hydrophobic acyl chains, forming a hydrogen bond with the hydroxyl group of Cremophor ® EL. In this study, the molecule of Span ® , which is structurally similar to γ-tocotrienol, may be docked in the hydrophobic pocket size in Cremophor ® . Chemically, Span ® 80, featuring unsaturated fatty acid side chains, may repulse the hydrophobic chain in Cremophor ® , attributing to smaller droplet size of emulsion than Span ® 20 (saturated fatty acid), as presented in Fig. 4 . From the results obtained, the SNEDDS formulation containing a mixture of Cremophor ® RH40 and Span ® 80 at a ratio that corresponded to an HLB of 10 was selected for loading a poorly water-soluble drug, NDP (about 30 mg/mL). The NDP-loaded SNEDDS was incubated at 25°C for 3 days. A yellow and clear solution was apparently observed without drug precipitation and phase separation. The SNEDDS formulation was diluted (100-fold) with distilled water and then kept for 2 h before droplet size measurements. Droplet size of both blank and NDP-loaded SNEDDS after dispersing in aqueous medium was found to be similar (approximately 73-74 nm), as shown in Table III . This confirmed the selfnanoemulsifying nature of SNEDDS.
Preparation and Characterization of Solid SNEDDS
The selected NDP-loaded SNEDDS formulation (using Imwitor ® 742 and mixed surfactant of Cremophor ® RH40 and Span ® 80, at an HLB value of 10) was adsorbed onto fumed silica (amorphous anhydrous colloidal silicon dioxide), i.e., (surface area of 110 m 2 /g), liquid SNEDDS was readily transformed to highly viscous oleogels regardless of the amount of adsorbent (i.e., 20-50% in the formulation). Figure 5 (Fig. 5a, b) . However, the solid SNEDDS appeared as smooth surface particles agglomerated to form larger particles (Fig. 5c, d) but with low intensity were observed in the physical mixture of NDP and Aerosil ® . All the SNEDDS and solid SNEDDS formulations did not show the characteristic peaks of NDP. These findings suggest that the NDP crystals are converted into the amorphous form in the SNEDDS.
In Vitro Dissolution Test
In vitro dissolution experiments were conducted to evaluate the effect of different types and amounts of adsorbent on the dissolution of NDP from the solid SNEDDS formulations. Figure 8 shows the percentage of NDP dissolved from different formulations in SGF. NDP dissolution in SGF was incomplete, i.e., approximately 10% of NDP dissolved, and precipitation of NDP was observed. In the self-emulsifying system, a mixture of oil, surfactant, and drug forms oil-inwater emulsions when introduced into an aqueous phase. It is suggested that the oil/surfactant and water phases effectively swell, decrease the oil droplet size, and eventually increase the dissolution rate. As shown in Fig. 8 , the dissolution of NDP from SNEDDS and solid SNEDDS was significantly improved, compared with the NDP powder, and no precipitation was noticed until the end of the experiment. This might be due to the increased effective surface area and alteration in the native crystalline form of the drug, as discussed previously.
The liquid SNEDDS formulation gave dissolution of approximately 90% within 10 min, after the dissolution of hard gelatin capsule, as a result of fast spontaneous emulsion formation. The drug dissolution from solid SNEDDS formulations was lower than that of liquid SNEDDS. It is possible that the desorption process from the adsorbent may delay the first step of drug dissolution. Moreover, excipients such as Aerosil ® may have a relatively strong interaction with the adsorbed SNEDDS, impairing the dissolution and extent of NDP. The percentage of NDP dissolved in SGF at 20 and 120 min is shown in 
CONCLUSION
The present study has demonstrated the development of the SNEDDS based on the HLB of mixed surfactants. Depending on the molecular structure of the surfactants used, the change in HLB affected the size of emulsion droplets after dispersing in the aqueous medium. The use of Cremophor ® / Span ® blends resulted in SNEDDS that can produce nanosized emulsions after dispersion. The selected formulation was adsorbed onto Aerosil ® 200 or Aerosil ® R972 to produce solid SNEDDS. The formulations using higher amounts (30-50% w/w) of Aerosil ® 200 exhibited good flow properties with smooth surface and preserved the self-emulsifying properties of liquid SNEDDS. The DSC and PXRD analyses indicated that NDP in solid SNEDDS may be in the molecular dispersion state. In vitro dissolution study demonstrated greater drug dissolution profiles of solid SNEDDS compared with NDP. It is concluded that the NDP-loaded solid S N E D D S c o n t a i n i n g m i x e d s u r f a c t a n t s f o r o r a l administration is a promising dosage form with good in vitro pharmaceutical results.
